Cargando…
Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases
The enzyme N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) was originally identified as a lysosomal enzyme which was deficient in Mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy Syndrome). The newly directed attention to the impact of ARSB in human pathobiology indicates a broader, more p...
Autores principales: | Tobacman, Joanne K., Bhattacharyya, Sumit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654056/ https://www.ncbi.nlm.nih.gov/pubmed/36361933 http://dx.doi.org/10.3390/ijms232113146 |
Ejemplares similares
-
Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase): Potential Role
as a Biomarker in Prostate Cancer
por: Feferman, Leo, et al.
Publicado: (2013) -
Increased Cerebral Serum Amyloid A2 and Parameters of Oxidation in Arylsulfatase B (N-Acetylgalactosamine-4-Sulfatase)-Null Mice
por: Bhattacharyya, Sumit, et al.
Publicado: (2023) -
Abstract 1936: Increases in expression of carbohydrate sulfotransferases CHST11 and CHST15 and decline in N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) require phospho-p38-MAPK following exposure to SARS-CoV-2 spike protein receptor binding domain in human a
por: Tobacman, Joanne, et al.
Publicado: (2023) -
Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia
por: Bhattacharyya, Sumit, et al.
Publicado: (2012) -
Decline in arylsulfatase B leads to increased invasiveness of melanoma cells
por: Bhattacharyya, Sumit, et al.
Publicado: (2016)